Instylla Pivotal HALT Study of Embrace Hydrogel Embolic Syst

January 10, 2023—Instylla, Inc. announced the enrollment of the first patient in the pivotal HALT study of the company’s first product, th

Related Keywords

Boston , Massachusetts , United States , California , Long Beach , Bedford , Suvranu Ganguli , David Tahour , Instylla Inc , Boston Medical Center , Section Chief , Interventional Radiology , Memorialcare Long Beach Medical Center , Liquid Embolic , Eripheral Vascular Embolotherapy , Salt Study , Eripheral Arterial Bleed , Embrace Hydrogel Embolic System , Gastrointestinal Bleeding , Transcatheter Arterial Embolization , Ae , Embolization ,